I'm keen to understand if someone has been looking into the potential continuous disclosure issue further?
and what avenues we as smaller shareholders have here for the matter to be looked at further?
- Forums
- ASX - By Stock
- Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette
MYX
mayne pharma group limited
Add to My Watchlist
2.30%
!
$5.34

I'm keen to understand if someone has been looking into the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.34 |
Change
0.120(2.30%) |
Mkt cap ! $433.8M |
Open | High | Low | Value | Volume |
$5.29 | $5.34 | $5.15 | $705.4K | 133.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | $5.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.34 | 3653 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | 5.310 |
1 | 864 | 5.290 |
1 | 28009 | 5.280 |
2 | 2631 | 5.250 |
1 | 402 | 5.240 |
Price($) | Vol. | No. |
---|---|---|
5.340 | 3653 | 3 |
5.350 | 16680 | 3 |
5.370 | 1631 | 1 |
5.390 | 1631 | 1 |
5.400 | 26805 | 3 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online